Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2015 08:00 ET | Source: Macrocure

Macrocure Hires Lewis Gryziewicz as Vice President, Regulatory Affairs

PETACH TIKVA, Israel, May 4, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and...
April 28, 2015 08:00 ET | Source: Macrocure

Macrocure Ltd. to Participate in Upcoming Annual Meeting of The Association for Research in Vision & Ophthalmology (ARVO)

PETACH TIKVA, Israel, April 28, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
April 21, 2015 08:00 ET | Source: Macrocure

Macrocure Ltd. Announces First Quarter 2015 Financial Results Date and Conference Call

PETACH TIKVA, Israel, April 21, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
April 13, 2015 09:00 ET | Source: Macrocure

Macrocure Ltd. to Participate in Upcoming Symposium on Advanced Wound Care

PETACH TIKVA, Israel, April 13, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
March 17, 2015 16:05 ET | Source: Macrocure

Macrocure Ltd. Provides Corporate Update and Reports Fourth Quarter and Full Year 2014 Financial Results

—Company announces anticipated timeline for DFU Phase III clinical trial results— —Company accelerates timelines for VLU Phase III clinical trial...
March 02, 2015 06:00 ET | Source: Macrocure

Macrocure Hires Dr. Ramesh Tharuvai, Ph.D. as Vice President, Operations

PETACH TIKVA, Israel, March 2, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
February 25, 2015 08:00 ET | Source: Macrocure

Macrocure Ltd. Announces Fourth Quarter and Full Year 2014 Financial Results Date and Conference Call

PETACH TIKVA, Israel, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
February 09, 2015 04:05 ET | Source: Macrocure

Macrocure Hires Mark Page as Chief Financial Officer

PETACH TIKVA, Israel, Feb. 9, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
February 05, 2015 12:00 ET | Source: Macrocure

Macrocure Announces Special General Meeting of Shareholders for Approval of Amendments to Compensation Package of CEO and 2013 Share Incentive Plan

PETACH TIKVA, Israel, Feb. 5, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
January 27, 2015 08:00 ET | Source: Macrocure

Macrocure Ltd. to Present at 17th Annual BIO CEO & Investor Conference

PETACH TIKVA, Israel, Jan. 27, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...